| 陆炳旭,高嘉良,陈光,等.中药单体治疗血脂异常的机制研究进展[J].中国临床保健杂志,2019,22(5):709-713. |
| 中药单体治疗血脂异常的机制研究进展 |
| A Review of the mechanism of Chinese Medicine Herbs and monomers for treating dyslipidemia |
| 投稿时间：2018-12-15 |
| DOI：10.3969/J.issn.1672-6790.2019.05.037 |
| 中文关键词: 血脂异常 胆固醇 甘油三酯类 植物提取物 降血脂药物 |
| 英文关键词: Dyslipidemias Cholesterol Triglycerides Plant extracts Hypolipidemic agents 〖FL |
| 基金项目:国家自然科学基金(81673847) |
|
| 摘要点击次数: 5322 |
| 全文下载次数: 4818 |
| 中文摘要: |
| 血脂异常是动脉粥样硬化性疾病的独立危险因素,临床常用他汀类降脂药物治疗。中医药可明显改善血脂异常,其中中药单体的研究逐年增多,机制逐渐明确,揭示了治疗血脂异常的中药治疗具有多靶点、多途径的特点。 |
| 英文摘要: |
| Dyslipidemia is an independent risk factor of atherosclerotic disease.Dyslipidemia is commonly treated with statins.Traditional Chinese medicine significantly improve dyslipidemia.As the studies on TCM herbal monomer increasing,the mechanism is gradually clear.It reveals that TCM treatment for dyslipidemia has the characteristics of multiple targets and multiple channels. |
|
查看全文
|
| 关闭 |